Menu
NASP

All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information

Featured Activity

Learn about treatment options, treatment failure, associated adverse effects and more.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

SHOW SEARCH

Specialty Technician CE: Cystic Fibrosis

To Participate

To participate in this continuing education activity:

  1. Review the activity description and objectives.
  2. View the activity.
  3. Complete the online post-test and activity evaluation.

This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.


 

A product of the National Association of Specialty Pharmacy's (NASP) Center for Specialty Pharmacy Education(CSPE). View more NASP/CSPE Activities
 

Activity Description

This overview of the Cystic Fibrosis (CF) disease state continuing education for pharmacy technicians covers a variety of topics related to treatment of CF. Topics include an overview of CF prevalence, risk factors, symptoms, and mechanism of disease; goals of therapy and prognosis of CF; current treatment options for CF; examples of workflow processes for CF technicians; programs to reduce medication copay; information on prior authorizations; and guidance for expanding the role of the pharmacy technician. The presentation is pertinent to Specialty Technicians, CF Clinic Liaisons, and other technicians seeking education on CF.

Learning Objectives

The target audience for this activity includes pharmacy technicians. Upon completion of this activity, participants will be able to:

  • Recognize the presentation, prevalence, and risk factors for Cystic Fibrosis (CF).
  • Describe the goals of therapy and prognosis of CF.
  • Outline current treatment options for CF.
  • Explain the important workflow processes to consider when dispensing medications to treat CF.

Faculty

Sabrina Sherwood, PharmD, BCPS
Cystic Fibrosis Clinical Pharmacist
St. Luke’s Cystic Fibrosis Center of Idaho
Boise, Idaho

Siera Zimmerman, PharmD, BCPPS, CPP
Clinical Pharmacist Specialist Pediatrics
Billings Clinic
Billings, Montana

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. None of the faculty have any relevant financial and/or commercial relationships to disclose.

CE Accreditation

Release Date: December 3, 2020
Expiration Date: December 3, 2023

Pharmacy Technicians

This CE activity is jointly provided by ProCE, Inc. and the National Association of Specialty Pharmacy (NASP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-421-H01-T has been assigned to this knowledge-based, home-study activity. This CE activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.

Funding

No external support has been received for this activity.

 

The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.